Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-04-04

Clinical Trial Update: Use of Botulinum Toxin to Treat Psoriasis [Phase 1]

View source ↗

Summary

Phase 1 study investigating botulinum toxin as a treatment for psoriasis vulgaris has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin (botulinum toxin)

Snippet

Sponsor: University of Minnesota | Conditions: Psoriasis Vulgaris | Phase 1 | Status: COMPLETED